🇺🇸 FDA
Patent

US 9446139

Polymer-based compositions and conjugates of HIV entry inhibitors

granted A61KA61K47/60A61P

Quick answer

US patent 9446139 (Polymer-based compositions and conjugates of HIV entry inhibitors) held by Nektar Therapeutics expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K47/60, A61P, A61P31/18